<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">

<pmc-articleset><article article-type="research-article" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<!--The publisher of this article does not allow downloading of the full text in XML form.-->
<front>
<journal-meta>
<journal-id journal-id-type="nlm-ta">J Physiol</journal-id>
<journal-id journal-id-type="iso-abbrev">J. Physiol. (Lond.)</journal-id>
<journal-id journal-id-type="doi">10.1111/(ISSN)1469-7793</journal-id>
<journal-id journal-id-type="publisher-id">TJP</journal-id>
<journal-id journal-id-type="hwp">jphysiol</journal-id>
<journal-title-group>
<journal-title>The Journal of Physiology</journal-title>
</journal-title-group>
<issn pub-type="ppub">0022-3751</issn>
<issn pub-type="epub">1469-7793</issn>
<publisher>
<publisher-name>John Wiley and Sons Inc.</publisher-name>
<publisher-loc>Hoboken</publisher-loc>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">26864374</article-id>
<article-id pub-id-type="pmc">4908029</article-id>
<article-id pub-id-type="doi">10.1113/JP271930</article-id>
<article-id pub-id-type="publisher-id">TJP7130</article-id>
<article-categories>
<subj-group subj-group-type="article-subject-classification">
<subject>Cellular and Molecular Physiology</subject>
</subj-group>
<subj-group subj-group-type="article-subject-classification">
<subject>Signalling Pathways</subject>
</subj-group>
<subj-group subj-group-type="overline">
<subject>Research Paper</subject>
</subj-group>
<subj-group subj-group-type="heading">
<subject>Molecular and Cellular</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Bioelectric signalling via potassium channels: a mechanism for craniofacial dysmorphogenesis in KCNJ2‐associated Andersen–Tawil Syndrome</article-title>
<alt-title alt-title-type="left-running-head">D. S. Adams and others</alt-title>
<alt-title alt-title-type="right-running-head">K<sup>+</sup>‐channels in craniofacial development</alt-title>
</title-group>
<contrib-group>
<contrib contrib-type="author" id="tjp7130-cr-0001">
<name>
<surname>Adams</surname>
<given-names>Dany Spencer</given-names>
</name>
<xref ref-type="aff" rid="tjp7130-aff-0001">
<sup>1</sup>
</xref>
</contrib>
<contrib contrib-type="author" id="tjp7130-cr-0002">
<name>
<surname>Uzel</surname>
<given-names>Sebastien G. M.</given-names>
</name>
<xref ref-type="aff" rid="tjp7130-aff-0002">
<sup>2</sup>
</xref>
</contrib>
<contrib contrib-type="author" id="tjp7130-cr-0003">
<name>
<surname>Akagi</surname>
<given-names>Jin</given-names>
</name>
<xref ref-type="aff" rid="tjp7130-aff-0003">
<sup>3</sup>
</xref>
</contrib>
<contrib contrib-type="author" id="tjp7130-cr-0004">
<name>
<surname>Wlodkowic</surname>
<given-names>Donald</given-names>
</name>
<xref ref-type="aff" rid="tjp7130-aff-0003">
<sup>3</sup>
</xref>
</contrib>
<contrib contrib-type="author" id="tjp7130-cr-0005">
<name>
<surname>Andreeva</surname>
<given-names>Viktoria</given-names>
</name>
<xref ref-type="aff" rid="tjp7130-aff-0004">
<sup>4</sup>
</xref>
</contrib>
<contrib contrib-type="author" id="tjp7130-cr-0006">
<name>
<surname>Yelick</surname>
<given-names>Pamela Crotty</given-names>
</name>
<xref ref-type="aff" rid="tjp7130-aff-0004">
<sup>4</sup>
</xref>
</contrib>
<contrib contrib-type="author" id="tjp7130-cr-0007">
<name>
<surname>Devitt‐Lee</surname>
<given-names>Adrian</given-names>
</name>
<xref ref-type="aff" rid="tjp7130-aff-0001">
<sup>1</sup>
</xref>
</contrib>
<contrib contrib-type="author" id="tjp7130-cr-0008">
<name>
<surname>Pare</surname>
<given-names>Jean‐Francois</given-names>
</name>
<xref ref-type="aff" rid="tjp7130-aff-0001">
<sup>1</sup>
</xref>
</contrib>
<contrib contrib-type="author" id="tjp7130-cr-0009">
<name>
<surname>Levin</surname>
<given-names>Michael</given-names>
</name>
<xref ref-type="aff" rid="tjp7130-aff-0001">
<sup>1</sup>
</xref>
</contrib>
</contrib-group>
<aff id="tjp7130-aff-0001">
<label>
<sup>1</sup>
</label>
<named-content content-type="organisation-division">Department of Biology and Tufts Centre for Regenerative and Developmental Biology</named-content>
<institution>Tufts University</institution>
<named-content content-type="street">200 Boston Avenue</named-content>
<named-content content-type="city">Medford</named-content>
<named-content content-type="country-part">MA</named-content>
<named-content content-type="post-code">02155</named-content>
<country country="US">USA</country>
</aff>
<aff id="tjp7130-aff-0002">
<label>
<sup>2</sup>
</label>
<named-content content-type="organisation-division">Department of Mechanical Engineering</named-content>
<institution>Massachusetts Institute of Technology</institution>
<named-content content-type="street">77 Massachusetts Avenue</named-content>
<named-content content-type="city">Cambridge</named-content>
<named-content content-type="country-part">MA</named-content>
<named-content content-type="post-code">02139</named-content>
<country country="US">USA</country>
</aff>
<aff id="tjp7130-aff-0003">
<label>
<sup>3</sup>
</label>
<named-content content-type="organisation-division">School of Applied Sciences</named-content>
<institution>RMIT University</institution>
<named-content content-type="country-part">Melbourne</named-content>
<country country="AU">Australia</country>
</aff>
<aff id="tjp7130-aff-0004">
<label>
<sup>4</sup>
</label>
<named-content content-type="organisation-division">Department of Orthodontics, Division of Craniofacial and Molecular Genetics</named-content>
<institution>Tufts University School of Dental Medicine</institution>
<named-content content-type="city">Boston</named-content>
<named-content content-type="country-part">MA 02111</named-content>
<country country="US">USA</country>
</aff>
<author-notes>
<corresp id="correspondenceTo"><bold>Corresponding author</bold> M. Levin: Department of Biology and Tufts Centre for Regenerative and Developmental Biology, Tufts University, 200 Boston Avenue, Medford, MA 02155, USA. Email: <email>michael.levin@tufts.edu</email></corresp>
</author-notes>
<pub-date pub-type="epub">
<day>13</day>
<month>4</month>
<year>2016</year>
</pub-date>
<pub-date pub-type="ppub">
<day>15</day>
<month>6</month>
<year>2016</year>
</pub-date>
<volume>594</volume>
<issue>12</issue>
<issue-id pub-id-type="doi">10.1113/tjp.2016.594.issue-12</issue-id>
<fpage>3245</fpage>
<lpage>3270</lpage>
<history>
<date date-type="received">
<day>19</day>
<month>11</month>
<year>2015</year>
</date>
<date date-type="accepted">
<day>01</day>
<month>2</month>
<year>2016</year>
</date>
</history>
<permissions>
<!--<copyright-statement content-type="issue-copyright"> Journal compilation &#x000a9; 2016 The Physiological Society <copyright-statement>-->
<copyright-statement content-type="article-copyright">© 2016 The Authors. The Journal of Physiology © 2016 The Physiological Society</copyright-statement>
</permissions>
<self-uri content-type="pdf" xlink:href="file:TJP-594-3245.pdf" xlink:type="simple"></self-uri>
<abstract>
<sec id="tjp7130-sec-0010">
<title>Key points</title>
<p>
<list id="tjp7130-list-0001" list-type="bullet"><list-item><p>
<italic>Xenopus laevis</italic> craniofacial development is a good system for the study of Andersen–Tawil Syndrome (ATS)‐associated craniofacial anomalies (CFAs) because (1) <italic>Kcnj2</italic> is expressed in the nascent face; (2) molecular‐genetic and biophysical techniques are available for the study of ion‐dependent signalling during craniofacial morphogenesis; (3) as in humans, expression of variant <italic>Kcnj2</italic> forms in embryos causes a muscle phenotype; and (4) variant forms of <italic>Kcnj2</italic> found in human patients, when injected into frog embryos, cause CFAs in the same cell lineages.</p></list-item><list-item><p>Forced expression of WT or variant <italic>Kcnj2</italic> changes the normal pattern of <italic>V</italic>
<sub>mem</sub> (resting potential) regionalization found in the ectoderm of neurulating embryos, and changes the normal pattern of expression of ten different genetic regulators of craniofacial development, including markers of cranial neural crest and of placodes.</p></list-item><list-item><p>Expression of other potassium channels and two different light‐activated channels, all of which have an effect on <italic>V</italic>
<sub>mem</sub>, causes CFAs like those induced by injection of <italic>Kcnj</italic>2 variants. In contrast, expression of <italic>Slc9A</italic> (NHE3), an electroneutral ion channel, and of <italic>GlyR</italic>, an inactive Cl<sup>−</sup> channel, do not cause CFAs, demonstrating that correct craniofacial development depends on a pattern of bioelectric states, not on ion‐ or channel‐specific signalling.</p></list-item><list-item><p>Using optogenetics to control both the location and the timing of ion flux in developing embryos, we show that affecting <italic>V</italic>
<sub>mem</sub> of the ectoderm and no other cell layers is sufficient to cause CFAs, but only during early neurula stages. Changes in <italic>V</italic>
<sub>mem</sub> induced late in neurulation do not affect craniofacial development.</p></list-item><list-item><p>We interpret these data as strong evidence, consistent with our hypothesis, that ATS‐associated CFAs are caused by the effect of variant <italic>Kcnj2</italic> on the <italic>V</italic>
<sub>mem</sub> of ectodermal cells of the developing face. We predict that the critical time is early during neurulation, and the critical cells are the ectodermal cranial neural crest and placode lineages. This points to the potential utility of extant, ion flux‐modifying drugs as treatments to prevent CFAs associated with channelopathies such as ATS.</p></list-item></list>
</p>
</sec>
<sec id="tjp7130-sec-0020">
<title>Abstract</title>
<p>Variants in potassium channel <italic>KCNJ2</italic> cause Andersen–Tawil Syndrome (ATS); the induced craniofacial anomalies (CFAs) are entirely unexplained. We show that <italic>KCNJ2</italic> is expressed in <italic>Xenopus</italic> and mouse during the earliest stages of craniofacial development. Misexpression in <italic>Xenopus</italic> of <italic>KCNJ2</italic> carrying ATS‐associated mutations causes CFAs in the same structures affected in humans, changes the normal pattern of membrane voltage potential regionalization in the developing face and disrupts expression of important craniofacial patterning genes, revealing the endogenous control of craniofacial patterning by bioelectric cell states. By altering cells’ resting potentials using other ion translocators, we show that a change in ectodermal voltage, not tied to a specific protein or ion, is sufficient to cause CFAs. By adapting optogenetics for use in non‐neural cells in embryos, we show that developmentally patterned K<sup>+</sup> flux is required for correct regionalization of the resting potentials and for establishment of endogenous early gene expression domains in the anterior ectoderm, and that variants in <italic>KCNJ2</italic> disrupt this regionalization, leading to the CFAs seen in ATS patients.</p>
</sec>
</abstract>
<abstract abstract-type="short">
<title>Key points</title>
<p>
<list id="tjp7130-list-0002" list-type="bullet"><list-item><p>
<italic>Xenopus laevis</italic> craniofacial development is a good system for the study of Andersen–Tawil Syndrome (ATS)‐associated craniofacial anomalies (CFAs) because (1) <italic>Kcnj2</italic> is expressed in the nascent face; (2) molecular‐genetic and biophysical techniques are available for the study of ion‐dependent signalling during craniofacial morphogenesis; (3) as in humans, expression of variant <italic>Kcnj2</italic> forms in embryos causes a muscle phenotype; and (4) variant forms of <italic>Kcnj2</italic> found in human patients, when injected into frog embryos, cause CFAs in the same cell lineages.</p></list-item><list-item><p>Forced expression of WT or variant <italic>Kcnj2</italic> changes the normal pattern of <italic>V</italic>
<sub>mem</sub> (resting potential) regionalization found in the ectoderm of neurulating embryos, and changes the normal pattern of expression of ten different genetic regulators of craniofacial development, including markers of cranial neural crest and of placodes.</p></list-item><list-item><p>Expression of other potassium channels and two different light‐activated channels, all of which have an effect on <italic>V</italic>
<sub>mem</sub>, causes CFAs like those induced by injection of <italic>Kcnj</italic>2 variants. In contrast, expression of <italic>Slc9A</italic> (NHE3), an electroneutral ion channel, and of <italic>GlyR</italic>, an inactive Cl<sup>−</sup> channel, do not cause CFAs, demonstrating that correct craniofacial development depends on a pattern of bioelectric states, not on ion‐ or channel‐specific signalling.</p></list-item><list-item><p>Using optogenetics to control both the location and the timing of ion flux in developing embryos, we show that affecting <italic>V</italic>
<sub>mem</sub> of the ectoderm and no other cell layers is sufficient to cause CFAs, but only during early neurula stages. Changes in <italic>V</italic>
<sub>mem</sub> induced late in neurulation do not affect craniofacial development.</p></list-item><list-item><p>We interpret these data as strong evidence, consistent with our hypothesis, that ATS‐associated CFAs are caused by the effect of variant <italic>Kcnj2</italic> on the <italic>V</italic>
<sub>mem</sub> of ectodermal cells of the developing face. We predict that the critical time is early during neurulation, and the critical cells are the ectodermal cranial neural crest and placode lineages. This points to the potential utility of extant, ion flux‐modifying drugs as treatments to prevent CFAs associated with channelopathies such as ATS.</p></list-item></list>
</p>
</abstract>
<counts>
<page-count count="26"></page-count>
</counts>
<custom-meta-group>
<custom-meta>
<meta-name>source-schema-version-number</meta-name>
<meta-value>2.0</meta-value>
</custom-meta>
<custom-meta>
<meta-name>component-id</meta-name>
<meta-value>tjp7130</meta-value>
</custom-meta>
<custom-meta>
<meta-name>cover-date</meta-name>
<meta-value>15 June 2016</meta-value>
</custom-meta>
<custom-meta>
<meta-name>details-of-publishers-convertor</meta-name>
<meta-value>Converter:WILEY_ML3GV2_TO_NLMPMC version:4.9.1 mode:remove_FC converted:14.06.2016</meta-value>
</custom-meta>
</custom-meta-group>
</article-meta>
</front>
</article>
</pmc-articleset>